Amarin Corp Plc (AMRN)

[HDGabor]

i-

do you think that TEVA committed induced infringement (promotion with press release, etc)?

Yes

do you think previous Hikma's PR is enough to demonstrate or support their induced infringement?

Most likely not. Definite answer: No
a.) Hikma’s press release makes no mention of an AB-rating
b.) no mention of any of the indications for Vascepa
(+c.) presentation of actual, PAST, Gross market of V is definitely is not)

Whether intentionally done or not, Hikma appears to have avoided the specific type of language that won GSK the CAFC ruling on Coreg. Generics have not launched yet, and given the (possible) implications of the Coreg decision, I believe generics would be extra careful to specifically exclude the CV indication in any product catalog or other such materials to avoid any potential induced infringement.

Best,
G